Free Trial
→ Read now. Do not delete. You’ve been warned. (From Porter & Company) (Ad)tc pixel Free BVC Stock Alerts

BATM Advanced Communications (BVC) Competitors

BATM Advanced Communications logo
GBX 12.60 -0.05 (-0.40%)
As of 06/5/2026 12:34 PM Eastern
Compare

BVC vs. TSTL, SPEC, AKR, ODX, and CNSL

Should you buy BATM Advanced Communications stock or one of its competitors? MarketBeat compares BATM Advanced Communications with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with BATM Advanced Communications include Tristel (TSTL), INSPECS Group (SPEC), Akers Biosciences (AKR), Omega Diagnostics Group (ODX), and Cambridge Nutritional Sciences (CNSL). These companies are all part of the "medical instruments & supplies" industry.

How does BATM Advanced Communications compare to Tristel?

Tristel (LON:TSTL) and BATM Advanced Communications (LON:BVC) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, risk, dividends, profitability, earnings, media sentiment, valuation and institutional ownership.

Tristel has higher earnings, but lower revenue than BATM Advanced Communications. BATM Advanced Communications is trading at a lower price-to-earnings ratio than Tristel, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Tristel£49.54M3.69£6.54M£16.2423.46
BATM Advanced Communications£123.20M0.35-£278.26K-£4.20N/A

In the previous week, Tristel and Tristel both had 1 articles in the media. BATM Advanced Communications' average media sentiment score of 1.10 beat Tristel's score of 0.00 indicating that BATM Advanced Communications is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Tristel
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
BATM Advanced Communications
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

22.0% of Tristel shares are owned by institutional investors. Comparatively, 16.9% of BATM Advanced Communications shares are owned by institutional investors. 21.0% of Tristel shares are owned by company insiders. Comparatively, 30.4% of BATM Advanced Communications shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Tristel presently has a consensus target price of GBX 400, suggesting a potential upside of 4.99%. Given Tristel's higher probable upside, research analysts plainly believe Tristel is more favorable than BATM Advanced Communications.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Tristel
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
BATM Advanced Communications
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Tristel has a beta of 0.333, meaning that its stock price is 67% less volatile than the broader market. Comparatively, BATM Advanced Communications has a beta of 0.727, meaning that its stock price is 27% less volatile than the broader market.

Tristel has a net margin of 15.88% compared to BATM Advanced Communications' net margin of -14.90%. Tristel's return on equity of 23.64% beat BATM Advanced Communications' return on equity.

Company Net Margins Return on Equity Return on Assets
Tristel15.88% 23.64% 9.89%
BATM Advanced Communications -14.90%-22.13%0.58%

Summary

Tristel beats BATM Advanced Communications on 9 of the 15 factors compared between the two stocks.

How does BATM Advanced Communications compare to INSPECS Group?

BATM Advanced Communications (LON:BVC) and INSPECS Group (LON:SPEC) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, profitability, earnings, risk, media sentiment, valuation, dividends and analyst recommendations.

16.9% of BATM Advanced Communications shares are held by institutional investors. Comparatively, 14.8% of INSPECS Group shares are held by institutional investors. 30.4% of BATM Advanced Communications shares are held by insiders. Comparatively, 21.0% of INSPECS Group shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

INSPECS Group has a net margin of -2.67% compared to BATM Advanced Communications' net margin of -14.90%. INSPECS Group's return on equity of -6.07% beat BATM Advanced Communications' return on equity.

Company Net Margins Return on Equity Return on Assets
BATM Advanced Communications-14.90% -22.13% 0.58%
INSPECS Group -2.67%-6.07%0.45%

INSPECS Group has a consensus price target of GBX 60, suggesting a potential downside of 28.99%. Given INSPECS Group's higher possible upside, analysts plainly believe INSPECS Group is more favorable than BATM Advanced Communications.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
BATM Advanced Communications
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
INSPECS Group
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

BATM Advanced Communications has a beta of 0.727, suggesting that its stock price is 27% less volatile than the broader market. Comparatively, INSPECS Group has a beta of 1.674, suggesting that its stock price is 67% more volatile than the broader market.

BATM Advanced Communications has higher earnings, but lower revenue than INSPECS Group. INSPECS Group is trading at a lower price-to-earnings ratio than BATM Advanced Communications, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BATM Advanced Communications£123.20M0.35-£278.26K-£4.20N/A
INSPECS Group£191.70M0.45-£4.11M-£9.40N/A

In the previous week, BATM Advanced Communications had 1 more articles in the media than INSPECS Group. MarketBeat recorded 1 mentions for BATM Advanced Communications and 0 mentions for INSPECS Group. BATM Advanced Communications' average media sentiment score of 1.10 beat INSPECS Group's score of 0.00 indicating that BATM Advanced Communications is being referred to more favorably in the media.

Company Overall Sentiment
BATM Advanced Communications Positive
INSPECS Group Neutral

Summary

BATM Advanced Communications beats INSPECS Group on 8 of the 14 factors compared between the two stocks.

How does BATM Advanced Communications compare to Akers Biosciences?

BATM Advanced Communications (LON:BVC) and Akers Biosciences (LON:AKR) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, profitability, valuation, institutional ownership, risk, earnings, media sentiment and analyst recommendations.

Akers Biosciences has lower revenue, but higher earnings than BATM Advanced Communications. BATM Advanced Communications is trading at a lower price-to-earnings ratio than Akers Biosciences, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BATM Advanced Communications£123.20M0.35-£278.26K-£4.20N/A
Akers Biosciences£2.32M0.00N/A-£129.60N/A

Akers Biosciences has a net margin of 0.00% compared to BATM Advanced Communications' net margin of -14.90%. Akers Biosciences' return on equity of 0.00% beat BATM Advanced Communications' return on equity.

Company Net Margins Return on Equity Return on Assets
BATM Advanced Communications-14.90% -22.13% 0.58%
Akers Biosciences N/A N/A N/A

In the previous week, BATM Advanced Communications had 1 more articles in the media than Akers Biosciences. MarketBeat recorded 1 mentions for BATM Advanced Communications and 0 mentions for Akers Biosciences. BATM Advanced Communications' average media sentiment score of 1.10 beat Akers Biosciences' score of 0.00 indicating that BATM Advanced Communications is being referred to more favorably in the media.

Company Overall Sentiment
BATM Advanced Communications Positive
Akers Biosciences Neutral

16.9% of BATM Advanced Communications shares are held by institutional investors. 30.4% of BATM Advanced Communications shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Given Akers Biosciences' higher probable upside, analysts clearly believe Akers Biosciences is more favorable than BATM Advanced Communications.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
BATM Advanced Communications
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Akers Biosciences
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Summary

BATM Advanced Communications beats Akers Biosciences on 9 of the 13 factors compared between the two stocks.

How does BATM Advanced Communications compare to Omega Diagnostics Group?

Omega Diagnostics Group (LON:ODX) and BATM Advanced Communications (LON:BVC) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their risk, analyst recommendations, dividends, valuation, profitability, earnings, institutional ownership and media sentiment.

In the previous week, BATM Advanced Communications had 1 more articles in the media than Omega Diagnostics Group. MarketBeat recorded 1 mentions for BATM Advanced Communications and 0 mentions for Omega Diagnostics Group. BATM Advanced Communications' average media sentiment score of 1.10 beat Omega Diagnostics Group's score of 0.00 indicating that BATM Advanced Communications is being referred to more favorably in the news media.

Company Overall Sentiment
Omega Diagnostics Group Neutral
BATM Advanced Communications Positive

BATM Advanced Communications has higher revenue and earnings than Omega Diagnostics Group. BATM Advanced Communications is trading at a lower price-to-earnings ratio than Omega Diagnostics Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Omega Diagnostics Group£7.55M0.00-£3.17M-£0.01N/A
BATM Advanced Communications£123.20M0.35-£278.26K-£4.20N/A

Omega Diagnostics Group has a beta of 3.85, suggesting that its stock price is 285% more volatile than the broader market. Comparatively, BATM Advanced Communications has a beta of 0.727, suggesting that its stock price is 27% less volatile than the broader market.

29.8% of Omega Diagnostics Group shares are owned by institutional investors. Comparatively, 16.9% of BATM Advanced Communications shares are owned by institutional investors. 50.6% of Omega Diagnostics Group shares are owned by insiders. Comparatively, 30.4% of BATM Advanced Communications shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

BATM Advanced Communications has a net margin of -14.90% compared to Omega Diagnostics Group's net margin of -51.15%. BATM Advanced Communications' return on equity of -22.13% beat Omega Diagnostics Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Omega Diagnostics Group-51.15% -29.14% -10.53%
BATM Advanced Communications -14.90%-22.13%0.58%

Given Omega Diagnostics Group's higher probable upside, analysts clearly believe Omega Diagnostics Group is more favorable than BATM Advanced Communications.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Omega Diagnostics Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
BATM Advanced Communications
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Summary

BATM Advanced Communications beats Omega Diagnostics Group on 10 of the 15 factors compared between the two stocks.

How does BATM Advanced Communications compare to Cambridge Nutritional Sciences?

BATM Advanced Communications (LON:BVC) and Cambridge Nutritional Sciences (LON:CNSL) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, risk, media sentiment, analyst recommendations, profitability, earnings, dividends and valuation.

BATM Advanced Communications has a beta of 0.727, indicating that its share price is 27% less volatile than the broader market. Comparatively, Cambridge Nutritional Sciences has a beta of 2.101, indicating that its share price is 110% more volatile than the broader market.

16.9% of BATM Advanced Communications shares are owned by institutional investors. Comparatively, 1.6% of Cambridge Nutritional Sciences shares are owned by institutional investors. 30.4% of BATM Advanced Communications shares are owned by insiders. Comparatively, 7.8% of Cambridge Nutritional Sciences shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
BATM Advanced Communications
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Cambridge Nutritional Sciences
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Cambridge Nutritional Sciences has a net margin of 16.94% compared to BATM Advanced Communications' net margin of -14.90%. Cambridge Nutritional Sciences' return on equity of 12.15% beat BATM Advanced Communications' return on equity.

Company Net Margins Return on Equity Return on Assets
BATM Advanced Communications-14.90% -22.13% 0.58%
Cambridge Nutritional Sciences 16.94%12.15%-2.36%

BATM Advanced Communications has higher revenue and earnings than Cambridge Nutritional Sciences. BATM Advanced Communications is trading at a lower price-to-earnings ratio than Cambridge Nutritional Sciences, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BATM Advanced Communications£123.20M0.35-£278.26K-£4.20N/A
Cambridge Nutritional Sciences£8.06M0.51-£3.03M£0.602.88

In the previous week, BATM Advanced Communications had 1 more articles in the media than Cambridge Nutritional Sciences. MarketBeat recorded 1 mentions for BATM Advanced Communications and 0 mentions for Cambridge Nutritional Sciences. BATM Advanced Communications' average media sentiment score of 1.10 beat Cambridge Nutritional Sciences' score of 0.00 indicating that BATM Advanced Communications is being referred to more favorably in the media.

Company Overall Sentiment
BATM Advanced Communications Positive
Cambridge Nutritional Sciences Neutral

Summary

BATM Advanced Communications beats Cambridge Nutritional Sciences on 9 of the 15 factors compared between the two stocks.

Get BATM Advanced Communications News Delivered to You Automatically

Sign up to receive the latest news and ratings for BVC and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BVC vs. The Competition

Export
MetricBATM Advanced CommunicationsMedical Instruments & Supplies IndustryMedical SectorLON Exchange
Market Cap£42.85M£2.81B£6.47B£2.77B
Dividend Yield3.52%2.03%2.67%6.12%
P/E Ratio-3.0016.4923.69364.79
Price / Sales0.3571.43520.6287,057.76
Price / Cash2.12146.5442.3527.85
Price / Book0.542.299.737.68
Net Income-£278.26K£99.80M£3.56B£5.89B
7 Day Performance-7.35%-1.63%-2.92%-0.50%
1 Month Performance-7.35%2.24%-0.85%2.10%
1 Year Performance-29.81%-8.62%22.23%72.87%

BATM Advanced Communications Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BVC
BATM Advanced Communications
1.3759 of 5 stars		GBX 12.60
-0.4%		N/A-24.4%£42.85M£123.20MN/A980
TSTL
Tristel
1.3663 of 5 stars		GBX 382.50
+2.7%		GBX 400
+4.6%		+7.3%£183.34M£49.54M23.55208
SPEC
INSPECS Group
0.5134 of 5 stars		GBX 85
+1.8%		GBX 60
-29.4%		+77.5%£86.42M£191.70MN/A1,673
AKR
Akers Biosciences
N/AN/AN/AN/A£21.64M£2.32MN/A120
ODX
Omega Diagnostics Group
N/AN/AN/AN/A£5.23M£7.55MN/A91

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (LON:BVC) was last updated on 6/6/2026 by MarketBeat.com Staff.
From Our Partners
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Pre-IPO Warning: SPCX [Watch Now!]
Tech investor James Altucher - who called Netflix, Facebook, and Bitcoin early - says the SpaceX IPO (Ticker: ...
Paradigm Press | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
How to get into the SpaceX IPO before June 12
Former tech executive and angel investor Jeff Brown - who identified Bitcoin, Tesla, and Nvidia before their h...
Brownstone Research | Sponsoredtc pixel
Tesla. SolarCity. Twitter. This $4 stock is next.
Elon Musk has a clear pattern: when a supplier becomes mission-critical, he acquires it. He bought SolarCity f...
Behind the Markets | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
She called ASTS before it ran 133%. Here's the system behind it.
Danielle Shay called AST SpaceMobile on Fox Business before it ran 133% - and found NBIS at $54 before it gapp...
Simpler Trading | Sponsoredtc pixel
Why is this free?
Simple Options Trading For Beginners normally sells for $29.97 - but right now Bill Poulos has opened a free w...
Profits Run | Sponsoredtc pixel